BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein BPC, supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compound: BPC-157 (Body Protection Compound-157). Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Format: lyophilised powder. Quantity: 5mg per vial. Purity: 98% minimum, analytically verified. Appearance: white lyophilised powder. Molecular weight: approximately 1419.5 g/mol. CAS number: 137525-51-0. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - BPC-157 is a stable synthetic fragment of a naturally occurring gastric protein and is among the most widely studied peptides in preclinical literature. Laboratory investigation has focused on its stability in gastric conditions, its behaviour in in-vitro tissue models, and its interaction with growth factor signalling pathways. Because the sequence is short and resistant to enzymatic degradation, it is frequently selected as a reference compound in peptide stability and bioavailability studies. Genesis Peptides supplies BPC-157 in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.